Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Urologic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Melanoma 1Lymphoma, Non-Hodgkin 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Adenoid Cystic 1

Interventions

pembrolizumab 7Nivolumab 3poly ICLC 2durvalumab 2Rituximab 2Gemcitabine 2Capecitabine 2utomilumab 1tremelimumab 1tanespimycin 1mirabegron 1entinostat 1ciforadenant 1cemiplimab 1Vorinostat 1Thalidomide 1Specimen Handling 1SUB1 protein, human 1SRA737 1Ritonavir 1Radiotherapy 1Radiation 1Polymerase Chain Reaction 1Paclitaxel 1Nicotine 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Injections, Subcutaneous 1Indinavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × GSK-3326595 × Lymphoid × Clear all
NCT02783300 2025-03-10

Meteor 1

GlaxoSmithKline

Phase 1 Completed
297 enrolled 76 charts
DermatologicGenitourinaryHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Adenoid Cystic, Lymphoma, Non-Hodgkin, Melanoma, Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡